Evidence map›Paper›PMID 30216744›Full record

ReviewAnnual review of pharmacology and toxicology2019

The Placebo Effect in Pain Therapies.

Luana Colloca

4 registry-linked trialsAbstract readReview
In one paragraph

Review in Annual review of pharmacology and toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 129 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03897998 phase2completednot on this mapstarted 2021, after this paper: background citation

Neural Correlates of Hypoalgesia Driven by Observation

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2021 to 2025Enrolled211ConditionsPain, Virtual Reality, PlaceboArmsNaloxone, Saline
NCT04851301 phase1 / phase2active not recruitingnot on this mapstarted 2021, after this paper: background citation

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2021 to 2026Enrolled259ConditionsPain, Virtual Reality, Placebo, Temporomandibular DisorderArmsActive Virtual Reality, sham Virtual Reality, No Intervention, Naloxone, Saline
NCT06030297 nacompletednot on this mapstarted 2023, after this paper: background citation

Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.

TypeinterventionalSponsorUniversity of UtahRan2023 to 2026Enrolled75ConditionsPeripheral NeuropathyArmsDiode Laser fiber type Selective Stimulator, ZTlido 1.8 % Topical System, PeriCam PSI NR, Medoc Quantitative Sensory Testing, Inactive Topical System
NCT06214923 narecruitingnot on this mapstarted 2024, after this paper: background citation

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2024 to 2026Enrolled78ConditionsPain, Virtual Reality, Placebo, Temporomandibular DisorderArmsRelieVRx, Sham-VR, No-VR (natural history control)
3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Luana CollocaDepartment of Pain and Translational Symptom Science, School of Nursing; Department of Anesthesiology, School of Medicine; and Center to Advance Chronic Pain Research, University of Maryland, Baltimore, Maryland 21201, USA; email: colloca@umaryland.edu.

Funding

Chronic orofacial pain: genetics, cognitive-emotional factors, and endogenous modulatory systemsR01DE025946 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI COLLOCA, LUANA · 2016 to 2019
$2.1M
NIDCR NIH HHS R01 DE025946
6 · The paper itself

Abstract

Pharmacological strategies for pain management have primarily focused on dampening ascending neurotransmission and on opioid receptor-mediated therapies. Little is known about the contribution of endogenous descending modulatory systems to clinical pain outcomes and why some patients are mildly affected while others suffer debilitating pain-induced dysfunctions. Placebo effects that arise from patients' positive expectancies and the underlying endogenous modulatory mechanisms may in part account for the variability in pain experience and severity, adherence to treatment, distinct coping strategies, and chronicity. Expectancy-induced analgesia and placebo effects in general have emerged as useful models to assess individual endogenous pain modulatory systems. Different systems and mechanisms trigger placebo effects that highly impact pain processing, clinical outcomes, and sense of well-being. This review illustrates critical elements of placebo mechanisms that inform the methodology of clinical trials, the discovery of new therapeutic targets, and the advancement of personalized pain management.

Indexed as

AnimalsClinical Trials as TopicHumansPainPain ManagementPlacebo EffectReceptors, OpioidReceptors, Opioidconditioningdose-extending placebosexpectationmodelingnoceboopioidsvasopressin

Identifiers

PMID30216744
PMCPMC6402571

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.